nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—Microtubule Inhibition—Paclitaxel—lung cancer	0.229	1	CiPCiCtD
Docetaxel—Paclitaxel—lung cancer	0.216	1	CrCtD
Docetaxel—Cabazitaxel—Paclitaxel—lung cancer	0.124	1	CrCrCtD
Docetaxel—melanoma—lung cancer	0.115	1	CtDrD
Docetaxel—EGFR—lung cancer	0.034	0.491	CbGaD
Docetaxel—ABCG2—lung cancer	0.0248	0.359	CbGaD
Docetaxel—ABCB1—lung cancer	0.0103	0.149	CbGaD
Docetaxel—MAP4—Paclitaxel—lung cancer	0.00976	0.0573	CbGbCtD
Docetaxel—MAPT—Paclitaxel—lung cancer	0.00705	0.0414	CbGbCtD
Docetaxel—MAP2—Paclitaxel—lung cancer	0.00705	0.0414	CbGbCtD
Docetaxel—EGFR—Gefitinib—lung cancer	0.00595	0.0349	CbGbCtD
Docetaxel—BCL2—Paclitaxel—lung cancer	0.0056	0.0329	CbGbCtD
Docetaxel—TUBB2A—Vinorelbine—lung cancer	0.00458	0.0269	CbGbCtD
Docetaxel—TUBB8—Vinorelbine—lung cancer	0.00458	0.0269	CbGbCtD
Docetaxel—TUBB6—Vinorelbine—lung cancer	0.00458	0.0269	CbGbCtD
Docetaxel—TUBB3—Vinorelbine—lung cancer	0.00458	0.0269	CbGbCtD
Docetaxel—TUBB2B—Vinorelbine—lung cancer	0.00458	0.0269	CbGbCtD
Docetaxel—TUBB4A—Vinorelbine—lung cancer	0.00458	0.0269	CbGbCtD
Docetaxel—TUBB—Vinorelbine—lung cancer	0.00383	0.0225	CbGbCtD
Docetaxel—TUBB4B—Vinorelbine—lung cancer	0.00383	0.0225	CbGbCtD
Docetaxel—TUBB1—Vinorelbine—lung cancer	0.00383	0.0225	CbGbCtD
Docetaxel—EGFR—Erlotinib—lung cancer	0.00352	0.0207	CbGbCtD
Docetaxel—TUBB3—Paclitaxel—lung cancer	0.00322	0.0189	CbGbCtD
Docetaxel—TUBB4A—Paclitaxel—lung cancer	0.00322	0.0189	CbGbCtD
Docetaxel—TUBB2A—Paclitaxel—lung cancer	0.00322	0.0189	CbGbCtD
Docetaxel—TUBB2B—Paclitaxel—lung cancer	0.00322	0.0189	CbGbCtD
Docetaxel—TUBB6—Paclitaxel—lung cancer	0.00322	0.0189	CbGbCtD
Docetaxel—TUBB8—Paclitaxel—lung cancer	0.00322	0.0189	CbGbCtD
Docetaxel—NR1I2—Erlotinib—lung cancer	0.0032	0.0188	CbGbCtD
Docetaxel—NR1I2—Paclitaxel—lung cancer	0.00293	0.0172	CbGbCtD
Docetaxel—TUBB8—Vinblastine—lung cancer	0.00282	0.0166	CbGbCtD
Docetaxel—TUBB4A—Vinblastine—lung cancer	0.00282	0.0166	CbGbCtD
Docetaxel—TUBB2B—Vinblastine—lung cancer	0.00282	0.0166	CbGbCtD
Docetaxel—TUBB3—Vinblastine—lung cancer	0.00282	0.0166	CbGbCtD
Docetaxel—TUBB2A—Vinblastine—lung cancer	0.00282	0.0166	CbGbCtD
Docetaxel—TUBB6—Vinblastine—lung cancer	0.00282	0.0166	CbGbCtD
Docetaxel—TUBB—Paclitaxel—lung cancer	0.00269	0.0158	CbGbCtD
Docetaxel—TUBB1—Paclitaxel—lung cancer	0.00269	0.0158	CbGbCtD
Docetaxel—TUBB4B—Paclitaxel—lung cancer	0.00269	0.0158	CbGbCtD
Docetaxel—TUBB4B—Vinblastine—lung cancer	0.00236	0.0139	CbGbCtD
Docetaxel—TUBB1—Vinblastine—lung cancer	0.00236	0.0139	CbGbCtD
Docetaxel—TUBB—Vinblastine—lung cancer	0.00236	0.0139	CbGbCtD
Docetaxel—ABCC10—Gemcitabine—lung cancer	0.00228	0.0134	CbGbCtD
Docetaxel—ABCC10—Paclitaxel—lung cancer	0.00206	0.0121	CbGbCtD
Docetaxel—ABCC10—Etoposide—lung cancer	0.00163	0.00955	CbGbCtD
Docetaxel—CYP1B1—Erlotinib—lung cancer	0.00122	0.00717	CbGbCtD
Docetaxel—SLCO1B3—Paclitaxel—lung cancer	0.00115	0.00675	CbGbCtD
Docetaxel—CYP1B1—Paclitaxel—lung cancer	0.00112	0.00657	CbGbCtD
Docetaxel—ABCC10—Doxorubicin—lung cancer	0.00111	0.00651	CbGbCtD
Docetaxel—ABCC10—Methotrexate—lung cancer	0.00107	0.00631	CbGbCtD
Docetaxel—ABCG2—Topotecan—lung cancer	0.00107	0.00631	CbGbCtD
Docetaxel—ABCG2—Gefitinib—lung cancer	0.000982	0.00577	CbGbCtD
Docetaxel—ABCG2—Teniposide—lung cancer	0.000952	0.00559	CbGbCtD
Docetaxel—ABCC1—Paclitaxel—lung cancer	0.000794	0.00466	CbGbCtD
Docetaxel—ABCC1—Irinotecan—lung cancer	0.000783	0.0046	CbGbCtD
Docetaxel—ABCC1—Vinblastine—lung cancer	0.000697	0.00409	CbGbCtD
Docetaxel—ABCC1—Etoposide—lung cancer	0.000628	0.00369	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—lung cancer	0.000602	0.00354	CbGbCtD
Docetaxel—SLCO1B3—Methotrexate—lung cancer	0.0006	0.00352	CbGbCtD
Docetaxel—ABCC2—Paclitaxel—lung cancer	0.000588	0.00345	CbGbCtD
Docetaxel—ABCG2—Erlotinib—lung cancer	0.000581	0.00341	CbGbCtD
Docetaxel—ABCC2—Irinotecan—lung cancer	0.00058	0.00341	CbGbCtD
Docetaxel—CYP3A5—Gefitinib—lung cancer	0.000544	0.0032	CbGbCtD
Docetaxel—KIF11—respiratory system—lung cancer	0.000543	0.0529	CbGeAlD
Docetaxel—ABCG2—Paclitaxel—lung cancer	0.000531	0.00312	CbGbCtD
Docetaxel—SLC22A7—Methotrexate—lung cancer	0.000528	0.0031	CbGbCtD
Docetaxel—CYP3A5—Teniposide—lung cancer	0.000528	0.0031	CbGbCtD
Docetaxel—ABCG2—Irinotecan—lung cancer	0.000524	0.00308	CbGbCtD
Docetaxel—ABCC2—Vinblastine—lung cancer	0.000516	0.00303	CbGbCtD
Docetaxel—ABCC2—Cisplatin—lung cancer	0.000473	0.00278	CbGbCtD
Docetaxel—ABCC2—Etoposide—lung cancer	0.000464	0.00273	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—lung cancer	0.000428	0.00251	CbGbCtD
Docetaxel—ABCG2—Cisplatin—lung cancer	0.000427	0.00251	CbGbCtD
Docetaxel—ABCG2—Etoposide—lung cancer	0.00042	0.00247	CbGbCtD
Docetaxel—ABCC1—Methotrexate—lung cancer	0.000415	0.00244	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.000393	0.00231	CbGbCtD
Docetaxel—CYP3A7—Paclitaxel—lung cancer	0.000393	0.00231	CbGbCtD
Docetaxel—CYP3A7—Irinotecan—lung cancer	0.000387	0.00227	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.000387	0.00227	CbGbCtD
Docetaxel—ABCB1—Topotecan—lung cancer	0.000387	0.00227	CbGbCtD
Docetaxel—MAP4—mammary gland—lung cancer	0.000375	0.0366	CbGeAlD
Docetaxel—ABCB1—Gefitinib—lung cancer	0.000354	0.00208	CbGbCtD
Docetaxel—EGFR—mammary gland—lung cancer	0.000337	0.0329	CbGeAlD
Docetaxel—CYP3A5—Crizotinib—lung cancer	0.000333	0.00196	CbGbCtD
Docetaxel—CYP3A5—Erlotinib—lung cancer	0.000322	0.00189	CbGbCtD
Docetaxel—KIF11—bone marrow—lung cancer	0.000318	0.031	CbGeAlD
Docetaxel—ABCC2—Doxorubicin—lung cancer	0.000317	0.00186	CbGbCtD
Docetaxel—ABCC2—Methotrexate—lung cancer	0.000307	0.0018	CbGbCtD
Docetaxel—CYP3A5—Paclitaxel—lung cancer	0.000294	0.00173	CbGbCtD
Docetaxel—CYP3A5—Irinotecan—lung cancer	0.00029	0.00171	CbGbCtD
Docetaxel—KIF11—lung—lung cancer	0.000288	0.0281	CbGeAlD
Docetaxel—ABCG2—Doxorubicin—lung cancer	0.000286	0.00168	CbGbCtD
Docetaxel—ABCG2—Methotrexate—lung cancer	0.000277	0.00163	CbGbCtD
Docetaxel—ABCB1—Vinorelbine—lung cancer	0.000273	0.0016	CbGbCtD
Docetaxel—MAP4—respiratory system—lung cancer	0.00025	0.0244	CbGeAlD
Docetaxel—TUBB3—respiratory system—lung cancer	0.00025	0.0244	CbGeAlD
Docetaxel—CYP3A5—Etoposide—lung cancer	0.000233	0.00137	CbGbCtD
Docetaxel—CYP3A4—Topotecan—lung cancer	0.000232	0.00136	CbGbCtD
Docetaxel—BCL2—respiratory system—lung cancer	0.000227	0.0222	CbGeAlD
Docetaxel—ABCB1—Crizotinib—lung cancer	0.000217	0.00127	CbGbCtD
Docetaxel—CYP3A4—Gefitinib—lung cancer	0.000212	0.00125	CbGbCtD
Docetaxel—ABCB1—Gemcitabine—lung cancer	0.000212	0.00125	CbGbCtD
Docetaxel—ABCB1—Erlotinib—lung cancer	0.000209	0.00123	CbGbCtD
Docetaxel—CYP3A4—Teniposide—lung cancer	0.000206	0.00121	CbGbCtD
Docetaxel—TUBB6—mammary gland—lung cancer	0.000205	0.02	CbGeAlD
Docetaxel—KIF11—lymph node—lung cancer	0.000197	0.0192	CbGeAlD
Docetaxel—MAP2—respiratory system—lung cancer	0.000197	0.0192	CbGeAlD
Docetaxel—ABCB1—Paclitaxel—lung cancer	0.000192	0.00113	CbGbCtD
Docetaxel—BCL2—epithelium—lung cancer	0.00019	0.0185	CbGeAlD
Docetaxel—ABCB1—Irinotecan—lung cancer	0.000189	0.00111	CbGbCtD
Docetaxel—TUBB4B—mammary gland—lung cancer	0.000178	0.0174	CbGeAlD
Docetaxel—Cabazitaxel—ABCG2—lung cancer	0.000176	0.391	CrCbGaD
Docetaxel—ABCB1—Vinblastine—lung cancer	0.000168	0.000987	CbGbCtD
Docetaxel—CYP3A4—Vinorelbine—lung cancer	0.000163	0.00096	CbGbCtD
Docetaxel—MAP2—bronchus—lung cancer	0.000162	0.0158	CbGeAlD
Docetaxel—ABCB1—Cisplatin—lung cancer	0.000154	0.000905	CbGbCtD
Docetaxel—TUBB4A—respiratory system—lung cancer	0.000152	0.0148	CbGeAlD
Docetaxel—ABCB1—Etoposide—lung cancer	0.000151	0.000889	CbGbCtD
Docetaxel—KIF11—Irinotecan—Topotecan—lung cancer	0.000148	0.202	CbGdCrCtD
Docetaxel—TUBB2B—respiratory system—lung cancer	0.000147	0.0143	CbGeAlD
Docetaxel—MAP2—trachea—lung cancer	0.000146	0.0142	CbGeAlD
Docetaxel—TUBB1—bone marrow—lung cancer	0.000143	0.014	CbGeAlD
Docetaxel—Paclitaxel—ABCG2—lung cancer	0.000142	0.315	CrCbGaD
Docetaxel—CYP1B1—mammary gland—lung cancer	0.000141	0.0138	CbGeAlD
Docetaxel—TUBB2A—respiratory system—lung cancer	0.000139	0.0135	CbGeAlD
Docetaxel—MAP2—cardiac atrium—lung cancer	0.000137	0.0133	CbGeAlD
Docetaxel—TUBB6—respiratory system—lung cancer	0.000137	0.0133	CbGeAlD
Docetaxel—BCL2—bone marrow—lung cancer	0.000133	0.013	CbGeAlD
Docetaxel—TUBB3—lung—lung cancer	0.000133	0.013	CbGeAlD
Docetaxel—MAP4—lung—lung cancer	0.000133	0.013	CbGeAlD
Docetaxel—CYP3A4—Crizotinib—lung cancer	0.00013	0.000764	CbGbCtD
Docetaxel—CYP3A4—Erlotinib—lung cancer	0.000125	0.000737	CbGbCtD
Docetaxel—KIF11—Topotecan—Irinotecan—lung cancer	0.000123	0.168	CbGdCrCtD
Docetaxel—TUBB2B—bronchus—lung cancer	0.000121	0.0118	CbGeAlD
Docetaxel—BCL2—lung—lung cancer	0.000121	0.0118	CbGeAlD
Docetaxel—EGFR—lung—lung cancer	0.000119	0.0116	CbGeAlD
Docetaxel—TUBB4B—respiratory system—lung cancer	0.000119	0.0116	CbGeAlD
Docetaxel—SLCO1B3—lung—lung cancer	0.000116	0.0113	CbGeAlD
Docetaxel—MAPT—lymph node—lung cancer	0.000116	0.0113	CbGeAlD
Docetaxel—CYP3A4—Paclitaxel—lung cancer	0.000115	0.000674	CbGbCtD
Docetaxel—TUBB—bronchus—lung cancer	0.000115	0.0112	CbGeAlD
Docetaxel—TUBB6—epithelium—lung cancer	0.000114	0.0111	CbGeAlD
Docetaxel—TUBB2A—bronchus—lung cancer	0.000114	0.0111	CbGeAlD
Docetaxel—CYP3A4—Irinotecan—lung cancer	0.000113	0.000665	CbGbCtD
Docetaxel—TUBB6—bronchus—lung cancer	0.000112	0.011	CbGeAlD
Docetaxel—TUBB2B—trachea—lung cancer	0.000109	0.0106	CbGeAlD
Docetaxel—BCL2—Irinotecan—Topotecan—lung cancer	0.000107	0.146	CbGdCrCtD
Docetaxel—MAP2—lung—lung cancer	0.000105	0.0102	CbGeAlD
Docetaxel—ABCB1—Doxorubicin—lung cancer	0.000103	0.000607	CbGbCtD
Docetaxel—TUBB—trachea—lung cancer	0.000103	0.01	CbGeAlD
Docetaxel—TUBB2A—trachea—lung cancer	0.000102	0.00998	CbGeAlD
Docetaxel—TUBB2B—cardiac atrium—lung cancer	0.000102	0.00996	CbGeAlD
Docetaxel—TUBB6—trachea—lung cancer	0.000101	0.00984	CbGeAlD
Docetaxel—CYP3A4—Vinblastine—lung cancer	0.000101	0.000592	CbGbCtD
Docetaxel—ABCB1—Methotrexate—lung cancer	0.0001	0.000588	CbGbCtD
Docetaxel—ABCC10—bronchus—lung cancer	9.84e-05	0.0096	CbGeAlD
Docetaxel—TUBB4B—bronchus—lung cancer	9.77e-05	0.00953	CbGeAlD
Docetaxel—TUBB—cardiac atrium—lung cancer	9.67e-05	0.00942	CbGeAlD
Docetaxel—TUBB2A—cardiac atrium—lung cancer	9.61e-05	0.00937	CbGeAlD
Docetaxel—TUBB6—cardiac atrium—lung cancer	9.48e-05	0.00925	CbGeAlD
Docetaxel—CYP1B1—respiratory system—lung cancer	9.41e-05	0.00917	CbGeAlD
Docetaxel—MAP4—lymph node—lung cancer	9.08e-05	0.00886	CbGeAlD
Docetaxel—CYP3A4—Etoposide—lung cancer	9.07e-05	0.000533	CbGbCtD
Docetaxel—ABCC10—trachea—lung cancer	8.84e-05	0.00862	CbGeAlD
Docetaxel—TUBB4B—trachea—lung cancer	8.78e-05	0.00856	CbGeAlD
Docetaxel—ABCC10—cardiac atrium—lung cancer	8.3e-05	0.0081	CbGeAlD
Docetaxel—BCL2—lymph node—lung cancer	8.26e-05	0.00805	CbGeAlD
Docetaxel—TUBB4B—cardiac atrium—lung cancer	8.24e-05	0.00804	CbGeAlD
Docetaxel—EGFR—lymph node—lung cancer	8.16e-05	0.00796	CbGeAlD
Docetaxel—TUBB—bone marrow—lung cancer	8.16e-05	0.00796	CbGeAlD
Docetaxel—TUBB2A—bone marrow—lung cancer	8.12e-05	0.00791	CbGeAlD
Docetaxel—TUBB4A—lung—lung cancer	8.08e-05	0.00788	CbGeAlD
Docetaxel—TUBB6—bone marrow—lung cancer	8.01e-05	0.00781	CbGeAlD
Docetaxel—TUBB2B—lung—lung cancer	7.81e-05	0.00762	CbGeAlD
Docetaxel—TUBB—lung—lung cancer	7.39e-05	0.00721	CbGeAlD
Docetaxel—TUBB2A—lung—lung cancer	7.35e-05	0.00717	CbGeAlD
Docetaxel—Cabazitaxel—ABCB1—lung cancer	7.34e-05	0.163	CrCbGaD
Docetaxel—TUBB6—lung—lung cancer	7.25e-05	0.00707	CbGeAlD
Docetaxel—TUBB3—Afatinib—Gefitinib—lung cancer	7.19e-05	0.0981	CbGdCrCtD
Docetaxel—MAP2—lymph node—lung cancer	7.15e-05	0.00697	CbGeAlD
Docetaxel—ABCC10—bone marrow—lung cancer	7.01e-05	0.00683	CbGeAlD
Docetaxel—ABCC1—bronchus—lung cancer	6.96e-05	0.00679	CbGeAlD
Docetaxel—TUBB4B—bone marrow—lung cancer	6.96e-05	0.00679	CbGeAlD
Docetaxel—CYP3A5—respiratory system—lung cancer	6.5e-05	0.00634	CbGeAlD
Docetaxel—ABCC10—lung—lung cancer	6.35e-05	0.00619	CbGeAlD
Docetaxel—TUBB4B—lung—lung cancer	6.31e-05	0.00615	CbGeAlD
Docetaxel—ABCC1—trachea—lung cancer	6.25e-05	0.0061	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—lung cancer	6.19e-05	0.000363	CbGbCtD
Docetaxel—Paclitaxel—ABCB1—lung cancer	5.93e-05	0.131	CrCbGaD
Docetaxel—ABCC1—cardiac atrium—lung cancer	5.87e-05	0.00573	CbGeAlD
Docetaxel—KIF11—Teniposide—Etoposide—lung cancer	5.55e-05	0.0757	CbGdCrCtD
Docetaxel—TUBB4A—lymph node—lung cancer	5.53e-05	0.00539	CbGeAlD
Docetaxel—TUBB2B—lymph node—lung cancer	5.34e-05	0.00521	CbGeAlD
Docetaxel—TUBB—lymph node—lung cancer	5.06e-05	0.00493	CbGeAlD
Docetaxel—TUBB2A—lymph node—lung cancer	5.03e-05	0.0049	CbGeAlD
Docetaxel—CYP1B1—lung—lung cancer	4.99e-05	0.00487	CbGeAlD
Docetaxel—TUBB6—lymph node—lung cancer	4.96e-05	0.00484	CbGeAlD
Docetaxel—KIF11—Vinblastine—Vinorelbine—lung cancer	4.78e-05	0.0652	CbGdCrCtD
Docetaxel—ABCC1—lung—lung cancer	4.49e-05	0.00438	CbGeAlD
Docetaxel—TUBB4B—Afatinib—Gefitinib—lung cancer	4.44e-05	0.0606	CbGdCrCtD
Docetaxel—ABCC10—lymph node—lung cancer	4.34e-05	0.00423	CbGeAlD
Docetaxel—TUBB4B—lymph node—lung cancer	4.31e-05	0.0042	CbGeAlD
Docetaxel—ABCG2—bone marrow—lung cancer	4.1e-05	0.004	CbGeAlD
Docetaxel—ABCG2—lung—lung cancer	3.72e-05	0.00363	CbGeAlD
Docetaxel—ABCC2—lymph node—lung cancer	3.49e-05	0.0034	CbGeAlD
Docetaxel—ABCB1—respiratory system—lung cancer	3.45e-05	0.00337	CbGeAlD
Docetaxel—CYP3A5—lung—lung cancer	3.45e-05	0.00337	CbGeAlD
Docetaxel—CYP1B1—lymph node—lung cancer	3.42e-05	0.00333	CbGeAlD
Docetaxel—TUBB6—Erlotinib—Gefitinib—lung cancer	3.39e-05	0.0462	CbGdCrCtD
Docetaxel—KIF11—Cytarabine—Gemcitabine—lung cancer	3.12e-05	0.0426	CbGdCrCtD
Docetaxel—ABCC1—lymph node—lung cancer	3.07e-05	0.003	CbGeAlD
Docetaxel—ABCB1—epithelium—lung cancer	2.89e-05	0.00281	CbGeAlD
Docetaxel—TUBB6—Zalcitabine—Gemcitabine—lung cancer	2.79e-05	0.038	CbGdCrCtD
Docetaxel—ABCB1—trachea—lung cancer	2.55e-05	0.00249	CbGeAlD
Docetaxel—ABCG2—lymph node—lung cancer	2.54e-05	0.00248	CbGeAlD
Docetaxel—TUBB6—Afatinib—Gefitinib—lung cancer	2.22e-05	0.0302	CbGdCrCtD
Docetaxel—ABCB1—bone marrow—lung cancer	2.02e-05	0.00197	CbGeAlD
Docetaxel—ABCB1—lung—lung cancer	1.83e-05	0.00179	CbGeAlD
Docetaxel—TUBB—Azacitidine—Gemcitabine—lung cancer	1.42e-05	0.0193	CbGdCrCtD
Docetaxel—ABCB1—lymph node—lung cancer	1.25e-05	0.00122	CbGeAlD
Docetaxel—Pneumonia—Methotrexate—lung cancer	6.28e-06	0.000159	CcSEcCtD
Docetaxel—Nasopharyngitis—Doxorubicin—lung cancer	6.27e-06	0.000159	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Cisplatin—lung cancer	6.26e-06	0.000158	CcSEcCtD
Docetaxel—Infestation NOS—Methotrexate—lung cancer	6.24e-06	0.000158	CcSEcCtD
Docetaxel—Infestation—Methotrexate—lung cancer	6.24e-06	0.000158	CcSEcCtD
Docetaxel—Anorexia—Paclitaxel—lung cancer	6.21e-06	0.000157	CcSEcCtD
Docetaxel—Hypotension—Etoposide—lung cancer	6.21e-06	0.000157	CcSEcCtD
Docetaxel—Pain—Cisplatin—lung cancer	6.2e-06	0.000157	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Methotrexate—lung cancer	6.19e-06	0.000156	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Doxorubicin—lung cancer	6.18e-06	0.000156	CcSEcCtD
Docetaxel—Vomiting—Vinorelbine—lung cancer	6.16e-06	0.000156	CcSEcCtD
Docetaxel—Body temperature increased—Gemcitabine—lung cancer	6.15e-06	0.000156	CcSEcCtD
Docetaxel—Renal failure—Methotrexate—lung cancer	6.13e-06	0.000155	CcSEcCtD
Docetaxel—Rash—Vinorelbine—lung cancer	6.11e-06	0.000154	CcSEcCtD
Docetaxel—Dermatitis—Vinorelbine—lung cancer	6.1e-06	0.000154	CcSEcCtD
Docetaxel—Hypotension—Paclitaxel—lung cancer	6.09e-06	0.000154	CcSEcCtD
Docetaxel—Stomatitis—Methotrexate—lung cancer	6.08e-06	0.000154	CcSEcCtD
Docetaxel—Headache—Vinorelbine—lung cancer	6.07e-06	0.000153	CcSEcCtD
Docetaxel—Conjunctivitis—Methotrexate—lung cancer	6.06e-06	0.000153	CcSEcCtD
Docetaxel—Dysphagia—Doxorubicin—lung cancer	6.06e-06	0.000153	CcSEcCtD
Docetaxel—Feeling abnormal—Cisplatin—lung cancer	5.98e-06	0.000151	CcSEcCtD
Docetaxel—Paraesthesia—Etoposide—lung cancer	5.97e-06	0.000151	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Paclitaxel—lung cancer	5.93e-06	0.00015	CcSEcCtD
Docetaxel—Dyspnoea—Etoposide—lung cancer	5.92e-06	0.00015	CcSEcCtD
Docetaxel—Somnolence—Etoposide—lung cancer	5.91e-06	0.000149	CcSEcCtD
Docetaxel—Angina pectoris—Doxorubicin—lung cancer	5.9e-06	0.000149	CcSEcCtD
Docetaxel—Hepatobiliary disease—Methotrexate—lung cancer	5.9e-06	0.000149	CcSEcCtD
Docetaxel—Insomnia—Paclitaxel—lung cancer	5.89e-06	0.000149	CcSEcCtD
Docetaxel—Epistaxis—Methotrexate—lung cancer	5.89e-06	0.000149	CcSEcCtD
Docetaxel—Hypersensitivity—Irinotecan—lung cancer	5.88e-06	0.000149	CcSEcCtD
Docetaxel—TUBB6—Azacitidine—Gemcitabine—lung cancer	5.86e-06	0.00799	CbGdCrCtD
Docetaxel—Paraesthesia—Paclitaxel—lung cancer	5.85e-06	0.000148	CcSEcCtD
Docetaxel—Agranulocytosis—Methotrexate—lung cancer	5.82e-06	0.000147	CcSEcCtD
Docetaxel—Dyspnoea—Paclitaxel—lung cancer	5.81e-06	0.000147	CcSEcCtD
Docetaxel—Somnolence—Paclitaxel—lung cancer	5.79e-06	0.000146	CcSEcCtD
Docetaxel—Decreased appetite—Etoposide—lung cancer	5.78e-06	0.000146	CcSEcCtD
Docetaxel—Pancytopenia—Doxorubicin—lung cancer	5.75e-06	0.000146	CcSEcCtD
Docetaxel—Nausea—Vinorelbine—lung cancer	5.75e-06	0.000145	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Etoposide—lung cancer	5.74e-06	0.000145	CcSEcCtD
Docetaxel—Dyspepsia—Paclitaxel—lung cancer	5.73e-06	0.000145	CcSEcCtD
Docetaxel—Body temperature increased—Cisplatin—lung cancer	5.73e-06	0.000145	CcSEcCtD
Docetaxel—Asthenia—Irinotecan—lung cancer	5.73e-06	0.000145	CcSEcCtD
Docetaxel—Fatigue—Etoposide—lung cancer	5.73e-06	0.000145	CcSEcCtD
Docetaxel—Pain—Etoposide—lung cancer	5.68e-06	0.000144	CcSEcCtD
Docetaxel—Constipation—Etoposide—lung cancer	5.68e-06	0.000144	CcSEcCtD
Docetaxel—Neutropenia—Doxorubicin—lung cancer	5.67e-06	0.000143	CcSEcCtD
Docetaxel—Decreased appetite—Paclitaxel—lung cancer	5.66e-06	0.000143	CcSEcCtD
Docetaxel—Haemoglobin—Methotrexate—lung cancer	5.63e-06	0.000142	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Paclitaxel—lung cancer	5.62e-06	0.000142	CcSEcCtD
Docetaxel—Fatigue—Paclitaxel—lung cancer	5.62e-06	0.000142	CcSEcCtD
Docetaxel—Haemorrhage—Methotrexate—lung cancer	5.6e-06	0.000142	CcSEcCtD
Docetaxel—Hepatitis—Methotrexate—lung cancer	5.6e-06	0.000142	CcSEcCtD
Docetaxel—Asthenia—Gemcitabine—lung cancer	5.58e-06	0.000141	CcSEcCtD
Docetaxel—Pain—Paclitaxel—lung cancer	5.57e-06	0.000141	CcSEcCtD
Docetaxel—Constipation—Paclitaxel—lung cancer	5.57e-06	0.000141	CcSEcCtD
Docetaxel—Pharyngitis—Methotrexate—lung cancer	5.56e-06	0.000141	CcSEcCtD
Docetaxel—Urinary tract disorder—Methotrexate—lung cancer	5.53e-06	0.00014	CcSEcCtD
Docetaxel—Weight increased—Doxorubicin—lung cancer	5.51e-06	0.000139	CcSEcCtD
Docetaxel—Pruritus—Gemcitabine—lung cancer	5.5e-06	0.000139	CcSEcCtD
Docetaxel—Urethral disorder—Methotrexate—lung cancer	5.49e-06	0.000139	CcSEcCtD
Docetaxel—Weight decreased—Doxorubicin—lung cancer	5.48e-06	0.000139	CcSEcCtD
Docetaxel—Feeling abnormal—Etoposide—lung cancer	5.47e-06	0.000138	CcSEcCtD
Docetaxel—Diarrhoea—Irinotecan—lung cancer	5.46e-06	0.000138	CcSEcCtD
Docetaxel—Pneumonia—Doxorubicin—lung cancer	5.43e-06	0.000137	CcSEcCtD
Docetaxel—Gastrointestinal pain—Etoposide—lung cancer	5.43e-06	0.000137	CcSEcCtD
Docetaxel—Infestation NOS—Doxorubicin—lung cancer	5.4e-06	0.000137	CcSEcCtD
Docetaxel—Infestation—Doxorubicin—lung cancer	5.4e-06	0.000137	CcSEcCtD
Docetaxel—Visual impairment—Methotrexate—lung cancer	5.4e-06	0.000137	CcSEcCtD
Docetaxel—Feeling abnormal—Paclitaxel—lung cancer	5.37e-06	0.000136	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—lung cancer	5.36e-06	0.000135	CcSEcCtD
Docetaxel—Hypersensitivity—Cisplatin—lung cancer	5.34e-06	0.000135	CcSEcCtD
Docetaxel—Gastrointestinal pain—Paclitaxel—lung cancer	5.33e-06	0.000135	CcSEcCtD
Docetaxel—Diarrhoea—Gemcitabine—lung cancer	5.32e-06	0.000135	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—lung cancer	5.31e-06	0.000134	CcSEcCtD
Docetaxel—Erythema multiforme—Methotrexate—lung cancer	5.3e-06	0.000134	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—lung cancer	5.3e-06	0.000134	CcSEcCtD
Docetaxel—Dizziness—Irinotecan—lung cancer	5.28e-06	0.000134	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—lung cancer	5.27e-06	0.000133	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—lung cancer	5.27e-06	0.000133	CcSEcCtD
Docetaxel—Body temperature increased—Etoposide—lung cancer	5.25e-06	0.000133	CcSEcCtD
Docetaxel—Abdominal pain—Etoposide—lung cancer	5.25e-06	0.000133	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—lung cancer	5.25e-06	0.000133	CcSEcCtD
Docetaxel—Eye disorder—Methotrexate—lung cancer	5.23e-06	0.000132	CcSEcCtD
Docetaxel—Asthenia—Cisplatin—lung cancer	5.2e-06	0.000132	CcSEcCtD
Docetaxel—Cardiac disorder—Methotrexate—lung cancer	5.2e-06	0.000131	CcSEcCtD
Docetaxel—Abdominal pain—Paclitaxel—lung cancer	5.15e-06	0.00013	CcSEcCtD
Docetaxel—Body temperature increased—Paclitaxel—lung cancer	5.15e-06	0.00013	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—lung cancer	5.11e-06	0.000129	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—lung cancer	5.1e-06	0.000129	CcSEcCtD
Docetaxel—Angiopathy—Methotrexate—lung cancer	5.08e-06	0.000129	CcSEcCtD
Docetaxel—Vomiting—Irinotecan—lung cancer	5.08e-06	0.000128	CcSEcCtD
Docetaxel—Immune system disorder—Methotrexate—lung cancer	5.06e-06	0.000128	CcSEcCtD
Docetaxel—Mediastinal disorder—Methotrexate—lung cancer	5.05e-06	0.000128	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—lung cancer	5.04e-06	0.000128	CcSEcCtD
Docetaxel—Rash—Irinotecan—lung cancer	5.04e-06	0.000127	CcSEcCtD
Docetaxel—Dermatitis—Irinotecan—lung cancer	5.03e-06	0.000127	CcSEcCtD
Docetaxel—Chills—Methotrexate—lung cancer	5.03e-06	0.000127	CcSEcCtD
Docetaxel—Headache—Irinotecan—lung cancer	5e-06	0.000127	CcSEcCtD
Docetaxel—Diarrhoea—Cisplatin—lung cancer	4.96e-06	0.000125	CcSEcCtD
Docetaxel—Alopecia—Methotrexate—lung cancer	4.95e-06	0.000125	CcSEcCtD
Docetaxel—Vomiting—Gemcitabine—lung cancer	4.95e-06	0.000125	CcSEcCtD
Docetaxel—Mental disorder—Methotrexate—lung cancer	4.91e-06	0.000124	CcSEcCtD
Docetaxel—Rash—Gemcitabine—lung cancer	4.91e-06	0.000124	CcSEcCtD
Docetaxel—Dermatitis—Gemcitabine—lung cancer	4.9e-06	0.000124	CcSEcCtD
Docetaxel—Hypersensitivity—Etoposide—lung cancer	4.89e-06	0.000124	CcSEcCtD
Docetaxel—Malnutrition—Methotrexate—lung cancer	4.88e-06	0.000123	CcSEcCtD
Docetaxel—Erythema—Methotrexate—lung cancer	4.88e-06	0.000123	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—lung cancer	4.87e-06	0.000123	CcSEcCtD
Docetaxel—Headache—Gemcitabine—lung cancer	4.87e-06	0.000123	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—lung cancer	4.86e-06	0.000123	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—lung cancer	4.85e-06	0.000123	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—lung cancer	4.85e-06	0.000123	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—lung cancer	4.83e-06	0.000122	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—lung cancer	4.81e-06	0.000122	CcSEcCtD
Docetaxel—Hypersensitivity—Paclitaxel—lung cancer	4.8e-06	0.000121	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—lung cancer	4.79e-06	0.000121	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—lung cancer	4.78e-06	0.000121	CcSEcCtD
Docetaxel—Dysgeusia—Methotrexate—lung cancer	4.77e-06	0.000121	CcSEcCtD
Docetaxel—Asthenia—Etoposide—lung cancer	4.77e-06	0.000121	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—lung cancer	4.77e-06	0.000121	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—lung cancer	4.75e-06	0.00012	CcSEcCtD
Docetaxel—Nausea—Irinotecan—lung cancer	4.74e-06	0.00012	CcSEcCtD
Docetaxel—Back pain—Methotrexate—lung cancer	4.72e-06	0.000119	CcSEcCtD
Docetaxel—Pruritus—Etoposide—lung cancer	4.7e-06	0.000119	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—lung cancer	4.67e-06	0.000118	CcSEcCtD
Docetaxel—Asthenia—Paclitaxel—lung cancer	4.67e-06	0.000118	CcSEcCtD
Docetaxel—Nausea—Gemcitabine—lung cancer	4.62e-06	0.000117	CcSEcCtD
Docetaxel—Vomiting—Cisplatin—lung cancer	4.61e-06	0.000117	CcSEcCtD
Docetaxel—Pruritus—Paclitaxel—lung cancer	4.61e-06	0.000117	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—lung cancer	4.59e-06	0.000116	CcSEcCtD
Docetaxel—Rash—Cisplatin—lung cancer	4.57e-06	0.000116	CcSEcCtD
Docetaxel—Dermatitis—Cisplatin—lung cancer	4.57e-06	0.000116	CcSEcCtD
Docetaxel—Diarrhoea—Etoposide—lung cancer	4.55e-06	0.000115	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—lung cancer	4.53e-06	0.000115	CcSEcCtD
Docetaxel—Anaemia—Methotrexate—lung cancer	4.51e-06	0.000114	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—lung cancer	4.5e-06	0.000114	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—lung cancer	4.5e-06	0.000114	CcSEcCtD
Docetaxel—Diarrhoea—Paclitaxel—lung cancer	4.46e-06	0.000113	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—lung cancer	4.4e-06	0.000111	CcSEcCtD
Docetaxel—Dizziness—Etoposide—lung cancer	4.39e-06	0.000111	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—lung cancer	4.38e-06	0.000111	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—lung cancer	4.37e-06	0.000111	CcSEcCtD
Docetaxel—Leukopenia—Methotrexate—lung cancer	4.36e-06	0.00011	CcSEcCtD
Docetaxel—Chills—Doxorubicin—lung cancer	4.35e-06	0.00011	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—lung cancer	4.33e-06	0.00011	CcSEcCtD
Docetaxel—Dizziness—Paclitaxel—lung cancer	4.31e-06	0.000109	CcSEcCtD
Docetaxel—Nausea—Cisplatin—lung cancer	4.31e-06	0.000109	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—lung cancer	4.29e-06	0.000108	CcSEcCtD
Docetaxel—Cough—Methotrexate—lung cancer	4.25e-06	0.000108	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—lung cancer	4.25e-06	0.000107	CcSEcCtD
Docetaxel—Convulsion—Methotrexate—lung cancer	4.22e-06	0.000107	CcSEcCtD
Docetaxel—Vomiting—Etoposide—lung cancer	4.22e-06	0.000107	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—lung cancer	4.22e-06	0.000107	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—lung cancer	4.22e-06	0.000107	CcSEcCtD
Docetaxel—Rash—Etoposide—lung cancer	4.19e-06	0.000106	CcSEcCtD
Docetaxel—Dermatitis—Etoposide—lung cancer	4.19e-06	0.000106	CcSEcCtD
Docetaxel—Headache—Etoposide—lung cancer	4.16e-06	0.000105	CcSEcCtD
Docetaxel—Arthralgia—Methotrexate—lung cancer	4.15e-06	0.000105	CcSEcCtD
Docetaxel—Chest pain—Methotrexate—lung cancer	4.15e-06	0.000105	CcSEcCtD
Docetaxel—Myalgia—Methotrexate—lung cancer	4.15e-06	0.000105	CcSEcCtD
Docetaxel—Vomiting—Paclitaxel—lung cancer	4.14e-06	0.000105	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—lung cancer	4.13e-06	0.000105	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.12e-06	0.000104	CcSEcCtD
Docetaxel—Rash—Paclitaxel—lung cancer	4.11e-06	0.000104	CcSEcCtD
Docetaxel—Dermatitis—Paclitaxel—lung cancer	4.1e-06	0.000104	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—lung cancer	4.08e-06	0.000103	CcSEcCtD
Docetaxel—Headache—Paclitaxel—lung cancer	4.08e-06	0.000103	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—lung cancer	4.06e-06	0.000103	CcSEcCtD
Docetaxel—Confusional state—Methotrexate—lung cancer	4.01e-06	0.000101	CcSEcCtD
Docetaxel—Anaphylactic shock—Methotrexate—lung cancer	3.98e-06	0.000101	CcSEcCtD
Docetaxel—Infection—Methotrexate—lung cancer	3.95e-06	0.0001	CcSEcCtD
Docetaxel—Nausea—Etoposide—lung cancer	3.95e-06	9.98e-05	CcSEcCtD
Docetaxel—Nervous system disorder—Methotrexate—lung cancer	3.9e-06	9.87e-05	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—lung cancer	3.9e-06	9.87e-05	CcSEcCtD
Docetaxel—Thrombocytopenia—Methotrexate—lung cancer	3.9e-06	9.85e-05	CcSEcCtD
Docetaxel—Nausea—Paclitaxel—lung cancer	3.87e-06	9.79e-05	CcSEcCtD
Docetaxel—Skin disorder—Methotrexate—lung cancer	3.87e-06	9.78e-05	CcSEcCtD
Docetaxel—Anorexia—Methotrexate—lung cancer	3.79e-06	9.59e-05	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—lung cancer	3.79e-06	9.58e-05	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—lung cancer	3.78e-06	9.56e-05	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—lung cancer	3.73e-06	9.44e-05	CcSEcCtD
Docetaxel—Hypotension—Methotrexate—lung cancer	3.72e-06	9.4e-05	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—lung cancer	3.71e-06	9.38e-05	CcSEcCtD
Docetaxel—Cough—Doxorubicin—lung cancer	3.68e-06	9.32e-05	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—lung cancer	3.66e-06	9.25e-05	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—lung cancer	3.65e-06	9.22e-05	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Methotrexate—lung cancer	3.63e-06	9.17e-05	CcSEcCtD
Docetaxel—Insomnia—Methotrexate—lung cancer	3.6e-06	9.1e-05	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—lung cancer	3.59e-06	9.09e-05	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—lung cancer	3.59e-06	9.09e-05	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—lung cancer	3.59e-06	9.09e-05	CcSEcCtD
Docetaxel—Paraesthesia—Methotrexate—lung cancer	3.57e-06	9.04e-05	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.57e-06	9.03e-05	CcSEcCtD
Docetaxel—Dyspnoea—Methotrexate—lung cancer	3.55e-06	8.97e-05	CcSEcCtD
Docetaxel—Somnolence—Methotrexate—lung cancer	3.54e-06	8.95e-05	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—lung cancer	3.52e-06	8.89e-05	CcSEcCtD
Docetaxel—Dyspepsia—Methotrexate—lung cancer	3.5e-06	8.86e-05	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—lung cancer	3.47e-06	8.79e-05	CcSEcCtD
Docetaxel—Decreased appetite—Methotrexate—lung cancer	3.46e-06	8.75e-05	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—lung cancer	3.45e-06	8.71e-05	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—lung cancer	3.45e-06	8.71e-05	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Methotrexate—lung cancer	3.44e-06	8.69e-05	CcSEcCtD
Docetaxel—Fatigue—Methotrexate—lung cancer	3.43e-06	8.68e-05	CcSEcCtD
Docetaxel—Infection—Doxorubicin—lung cancer	3.42e-06	8.66e-05	CcSEcCtD
Docetaxel—Pain—Methotrexate—lung cancer	3.4e-06	8.61e-05	CcSEcCtD
Docetaxel—Shock—Doxorubicin—lung cancer	3.39e-06	8.57e-05	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—lung cancer	3.38e-06	8.55e-05	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—lung cancer	3.37e-06	8.53e-05	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—lung cancer	3.36e-06	8.51e-05	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—lung cancer	3.35e-06	8.46e-05	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—lung cancer	3.28e-06	8.31e-05	CcSEcCtD
Docetaxel—Feeling abnormal—Methotrexate—lung cancer	3.28e-06	8.29e-05	CcSEcCtD
Docetaxel—Gastrointestinal pain—Methotrexate—lung cancer	3.25e-06	8.23e-05	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—lung cancer	3.22e-06	8.14e-05	CcSEcCtD
Docetaxel—Abdominal pain—Methotrexate—lung cancer	3.15e-06	7.96e-05	CcSEcCtD
Docetaxel—Body temperature increased—Methotrexate—lung cancer	3.15e-06	7.96e-05	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.14e-06	7.94e-05	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—lung cancer	3.12e-06	7.88e-05	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—lung cancer	3.09e-06	7.83e-05	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—lung cancer	3.07e-06	7.77e-05	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—lung cancer	3.06e-06	7.75e-05	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—lung cancer	3.03e-06	7.67e-05	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—lung cancer	3e-06	7.58e-05	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—lung cancer	2.97e-06	7.52e-05	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—lung cancer	2.97e-06	7.51e-05	CcSEcCtD
Docetaxel—Pain—Doxorubicin—lung cancer	2.95e-06	7.45e-05	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—lung cancer	2.95e-06	7.45e-05	CcSEcCtD
Docetaxel—Hypersensitivity—Methotrexate—lung cancer	2.93e-06	7.41e-05	CcSEcCtD
Docetaxel—Asthenia—Methotrexate—lung cancer	2.86e-06	7.22e-05	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—lung cancer	2.84e-06	7.18e-05	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—lung cancer	2.82e-06	7.13e-05	CcSEcCtD
Docetaxel—Pruritus—Methotrexate—lung cancer	2.82e-06	7.12e-05	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—lung cancer	2.72e-06	6.89e-05	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—lung cancer	2.72e-06	6.89e-05	CcSEcCtD
Docetaxel—Diarrhoea—Methotrexate—lung cancer	2.72e-06	6.89e-05	CcSEcCtD
Docetaxel—Dizziness—Methotrexate—lung cancer	2.63e-06	6.66e-05	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—lung cancer	2.54e-06	6.42e-05	CcSEcCtD
Docetaxel—Vomiting—Methotrexate—lung cancer	2.53e-06	6.4e-05	CcSEcCtD
Docetaxel—Rash—Methotrexate—lung cancer	2.51e-06	6.35e-05	CcSEcCtD
Docetaxel—Dermatitis—Methotrexate—lung cancer	2.51e-06	6.34e-05	CcSEcCtD
Docetaxel—Headache—Methotrexate—lung cancer	2.49e-06	6.3e-05	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—lung cancer	2.47e-06	6.25e-05	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—lung cancer	2.44e-06	6.17e-05	CcSEcCtD
Docetaxel—Nausea—Methotrexate—lung cancer	2.36e-06	5.98e-05	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—lung cancer	2.36e-06	5.96e-05	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—lung cancer	2.28e-06	5.76e-05	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—lung cancer	2.19e-06	5.54e-05	CcSEcCtD
Docetaxel—Rash—Doxorubicin—lung cancer	2.17e-06	5.49e-05	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—lung cancer	2.17e-06	5.49e-05	CcSEcCtD
Docetaxel—Headache—Doxorubicin—lung cancer	2.16e-06	5.46e-05	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—lung cancer	2.05e-06	5.18e-05	CcSEcCtD
Docetaxel—EGFR—Immune System—ERBB2—lung cancer	4.54e-07	1.77e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ENO1—lung cancer	4.52e-07	1.76e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.51e-07	1.76e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MDM2—lung cancer	4.51e-07	1.76e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RRM1—lung cancer	4.5e-07	1.76e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA3—lung cancer	4.5e-07	1.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—lung cancer	4.5e-07	1.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—lung cancer	4.5e-07	1.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RAF1—lung cancer	4.49e-07	1.75e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—lung cancer	4.49e-07	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TERT—lung cancer	4.48e-07	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CB—lung cancer	4.48e-07	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MTOR—lung cancer	4.48e-07	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—lung cancer	4.47e-07	1.74e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CREBBP—lung cancer	4.44e-07	1.73e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—lung cancer	4.44e-07	1.73e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTP1—lung cancer	4.43e-07	1.73e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—POMC—lung cancer	4.41e-07	1.72e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTOR—lung cancer	4.38e-07	1.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CB—lung cancer	4.38e-07	1.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—lung cancer	4.38e-07	1.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGFR1—lung cancer	4.35e-07	1.7e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—lung cancer	4.34e-07	1.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—lung cancer	4.33e-07	1.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—lung cancer	4.33e-07	1.69e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAT—lung cancer	4.31e-07	1.68e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CREBBP—lung cancer	4.3e-07	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HIF1A—lung cancer	4.29e-07	1.67e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—EP300—lung cancer	4.28e-07	1.67e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—lung cancer	4.27e-07	1.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MDM2—lung cancer	4.25e-07	1.66e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—B4GALT5—lung cancer	4.23e-07	1.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—RAF1—lung cancer	4.23e-07	1.65e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	4.22e-07	1.65e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CG—lung cancer	4.22e-07	1.64e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CD—lung cancer	4.21e-07	1.64e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCB1—lung cancer	4.19e-07	1.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—lung cancer	4.19e-07	1.63e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CG—lung cancer	4.18e-07	1.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—lung cancer	4.16e-07	1.62e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—lung cancer	4.16e-07	1.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—lung cancer	4.15e-07	1.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOA1—lung cancer	4.14e-07	1.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CB—lung cancer	4.13e-07	1.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTOR—lung cancer	4.13e-07	1.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—lung cancer	4.12e-07	1.61e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA4—lung cancer	4.12e-07	1.61e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TYMS—lung cancer	4.12e-07	1.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—lung cancer	4.11e-07	1.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—lung cancer	4.1e-07	1.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—lung cancer	4.09e-07	1.6e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—lung cancer	4.09e-07	1.59e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CD—lung cancer	4.07e-07	1.59e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—lung cancer	4.07e-07	1.59e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP2E1—lung cancer	4.05e-07	1.58e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—lung cancer	4.02e-07	1.57e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA2—lung cancer	4.01e-07	1.57e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—POMC—lung cancer	4.01e-07	1.57e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NQO1—lung cancer	4.01e-07	1.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—JUN—lung cancer	4e-07	1.56e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—POMC—lung cancer	3.98e-07	1.55e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CREBBP—lung cancer	3.91e-07	1.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1A—lung cancer	3.88e-07	1.51e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CREBBP—lung cancer	3.87e-07	1.51e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTA1—lung cancer	3.87e-07	1.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—lung cancer	3.87e-07	1.51e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1A1—lung cancer	3.86e-07	1.5e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCC3—lung cancer	3.83e-07	1.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—lung cancer	3.83e-07	1.49e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ERCC2—lung cancer	3.83e-07	1.49e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	3.82e-07	1.49e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1A—lung cancer	3.8e-07	1.48e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—lung cancer	3.79e-07	1.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—lung cancer	3.78e-07	1.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CG—lung cancer	3.78e-07	1.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KIT—lung cancer	3.78e-07	1.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—lung cancer	3.78e-07	1.47e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—lung cancer	3.77e-07	1.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EGF—lung cancer	3.73e-07	1.46e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKR1C1—lung cancer	3.71e-07	1.45e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CD—lung cancer	3.71e-07	1.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EP300—lung cancer	3.69e-07	1.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—lung cancer	3.67e-07	1.43e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CD—lung cancer	3.67e-07	1.43e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CB—lung cancer	3.67e-07	1.43e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—lung cancer	3.66e-07	1.43e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—lung cancer	3.64e-07	1.42e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—lung cancer	3.63e-07	1.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK3—lung cancer	3.62e-07	1.41e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EP300—lung cancer	3.61e-07	1.41e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—STK11—lung cancer	3.61e-07	1.41e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—UGT1A1—lung cancer	3.6e-07	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—POMC—lung cancer	3.59e-07	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SRC—lung cancer	3.59e-07	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1A—lung cancer	3.58e-07	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—lung cancer	3.57e-07	1.39e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CB—lung cancer	3.55e-07	1.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BRAF—lung cancer	3.55e-07	1.38e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—lung cancer	3.52e-07	1.37e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SRC—lung cancer	3.51e-07	1.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6R—lung cancer	3.51e-07	1.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CREBBP—lung cancer	3.5e-07	1.37e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNG11—lung cancer	3.47e-07	1.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—lung cancer	3.46e-07	1.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—lung cancer	3.45e-07	1.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—EP300—lung cancer	3.41e-07	1.33e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—lung cancer	3.39e-07	1.32e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—lung cancer	3.38e-07	1.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAP2K1—lung cancer	3.34e-07	1.3e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTP1—lung cancer	3.34e-07	1.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CD—lung cancer	3.32e-07	1.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SRC—lung cancer	3.31e-07	1.29e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOA1—lung cancer	3.31e-07	1.29e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALDOA—lung cancer	3.31e-07	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK3—lung cancer	3.3e-07	1.29e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAT—lung cancer	3.25e-07	1.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—lung cancer	3.25e-07	1.27e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK3—lung cancer	3.24e-07	1.26e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CB—lung cancer	3.23e-07	1.26e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NCOA3—lung cancer	3.21e-07	1.25e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CB—lung cancer	3.2e-07	1.25e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—lung cancer	3.2e-07	1.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—lung cancer	3.19e-07	1.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—lung cancer	3.19e-07	1.24e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—lung cancer	3.17e-07	1.24e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—lung cancer	3.17e-07	1.24e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—lung cancer	3.17e-07	1.24e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—lung cancer	3.15e-07	1.23e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADCY1—lung cancer	3.12e-07	1.22e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCG2—lung cancer	3.12e-07	1.22e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TYMS—lung cancer	3.11e-07	1.21e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—lung cancer	3.08e-07	1.2e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—lung cancer	3.07e-07	1.2e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—lung cancer	3.07e-07	1.2e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HPGDS—lung cancer	3.06e-07	1.19e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ENO2—lung cancer	3.06e-07	1.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK3—lung cancer	3.05e-07	1.19e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.04e-07	1.19e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—EP300—lung cancer	3.03e-07	1.18e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CG—lung cancer	3.02e-07	1.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—lung cancer	2.99e-07	1.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MDM2—lung cancer	2.97e-07	1.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—lung cancer	2.97e-07	1.16e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTT1—lung cancer	2.97e-07	1.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—lung cancer	2.97e-07	1.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RAF1—lung cancer	2.96e-07	1.16e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GCLC—lung cancer	2.94e-07	1.15e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2A6—lung cancer	2.94e-07	1.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—lung cancer	2.93e-07	1.14e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—EP300—lung cancer	2.93e-07	1.14e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1A1—lung cancer	2.91e-07	1.14e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—lung cancer	2.91e-07	1.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MTOR—lung cancer	2.89e-07	1.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CB—lung cancer	2.89e-07	1.13e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ERCC2—lung cancer	2.89e-07	1.13e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—POMC—lung cancer	2.88e-07	1.12e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CREBBP—lung cancer	2.8e-07	1.09e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—lung cancer	2.79e-07	1.09e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ENO1—lung cancer	2.78e-07	1.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—lung cancer	2.78e-07	1.08e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—lung cancer	2.77e-07	1.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—lung cancer	2.76e-07	1.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—lung cancer	2.74e-07	1.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—lung cancer	2.73e-07	1.06e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—lung cancer	2.67e-07	1.04e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—EP300—lung cancer	2.66e-07	1.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—lung cancer	2.66e-07	1.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—lung cancer	2.66e-07	1.04e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CD—lung cancer	2.66e-07	1.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—lung cancer	2.64e-07	1.03e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—EP300—lung cancer	2.64e-07	1.03e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—lung cancer	2.62e-07	1.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—lung cancer	2.59e-07	1.01e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—lung cancer	2.59e-07	1.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JUN—lung cancer	2.59e-07	1.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—lung cancer	2.52e-07	9.85e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—lung cancer	2.52e-07	9.83e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—lung cancer	2.52e-07	9.81e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1A—lung cancer	2.51e-07	9.78e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—lung cancer	2.5e-07	9.75e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOA1—lung cancer	2.5e-07	9.74e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2E1—lung cancer	2.5e-07	9.74e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—lung cancer	2.47e-07	9.65e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NQO1—lung cancer	2.47e-07	9.63e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—lung cancer	2.44e-07	9.52e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—lung cancer	2.42e-07	9.43e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EP300—lung cancer	2.38e-07	9.3e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—lung cancer	2.37e-07	9.23e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—lung cancer	2.33e-07	9.09e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SRC—lung cancer	2.32e-07	9.05e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CB—lung cancer	2.31e-07	9.03e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—lung cancer	2.29e-07	8.95e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CG—lung cancer	2.28e-07	8.89e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—lung cancer	2.26e-07	8.81e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—lung cancer	2.24e-07	8.73e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—lung cancer	2.24e-07	8.72e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—lung cancer	2.23e-07	8.7e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—lung cancer	2.23e-07	8.7e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—lung cancer	2.23e-07	8.7e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—STK11—lung cancer	2.22e-07	8.68e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—lung cancer	2.18e-07	8.52e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—POMC—lung cancer	2.17e-07	8.47e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—lung cancer	2.16e-07	8.45e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK3—lung cancer	2.14e-07	8.33e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CREBBP—lung cancer	2.11e-07	8.25e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—lung cancer	2.08e-07	8.11e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTP1—lung cancer	2.06e-07	8.03e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—lung cancer	2.06e-07	8.03e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CD—lung cancer	2e-07	7.82e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAT—lung cancer	2e-07	7.81e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—lung cancer	2e-07	7.8e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—lung cancer	1.98e-07	7.72e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—lung cancer	1.97e-07	7.68e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—lung cancer	1.95e-07	7.62e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCB1—lung cancer	1.95e-07	7.6e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—lung cancer	1.92e-07	7.49e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMS—lung cancer	1.91e-07	7.46e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—EP300—lung cancer	1.91e-07	7.44e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—lung cancer	1.89e-07	7.38e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—lung cancer	1.83e-07	7.13e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1A1—lung cancer	1.79e-07	7e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ERCC2—lung cancer	1.78e-07	6.94e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—lung cancer	1.77e-07	6.9e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—lung cancer	1.76e-07	6.88e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CB—lung cancer	1.75e-07	6.81e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—lung cancer	1.73e-07	6.75e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—lung cancer	1.71e-07	6.66e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—lung cancer	1.63e-07	6.37e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—lung cancer	1.61e-07	6.28e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—lung cancer	1.59e-07	6.22e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—lung cancer	1.56e-07	6.09e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOA1—lung cancer	1.54e-07	6e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—lung cancer	1.51e-07	5.89e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—lung cancer	1.44e-07	5.62e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—EP300—lung cancer	1.44e-07	5.62e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—lung cancer	1.41e-07	5.51e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CG—lung cancer	1.4e-07	5.48e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—POMC—lung cancer	1.34e-07	5.22e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CREBBP—lung cancer	1.3e-07	5.08e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CD—lung cancer	1.23e-07	4.82e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—lung cancer	1.22e-07	4.75e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—lung cancer	1.15e-07	4.5e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CB—lung cancer	1.08e-07	4.2e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—lung cancer	1.07e-07	4.16e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—lung cancer	1.06e-07	4.15e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—lung cancer	9.3e-08	3.63e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—EP300—lung cancer	8.87e-08	3.46e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—lung cancer	8.7e-08	3.39e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—lung cancer	6.56e-08	2.56e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—lung cancer	5.36e-08	2.09e-06	CbGpPWpGaD
